World's Best Scientists 2026 revealed!
Heather L. Davis

Heather L. Davis

D-Index & Metrics

Immunology

D-Index
66
Citations
17895
World Ranking
2740
National Ranking
115

Heather L. Davis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Heather L. Davis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 133 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Heather L. Davis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Heather L. Davis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Heather L. Davis is affiliated with Sanofi in France and has contributed extensively to medical research, with a primary focus on immunotherapy, infectious diseases, and surgical outcomes. Their body of work spans multiple intersecting fields including medicine, surgery, molecular biology, immunology, pulmonary and respiratory medicine, and epidemiology.

Their research topics emphasize immunotherapy and immune responses, hepatitis B virus studies, RNA interference and gene delivery, cardiac, anesthesia and surgical outcomes, enhanced recovery after surgery, abdominal surgery and complications, as well as esophageal and gastrointestinal pathology.

Heather L. Davis has published research in various prominent venues, including:

  • British Journal of Surgery
  • The Breast
  • Gut
  • Vaccines
  • Frontiers in Immunology

Their recent published papers include:

  • Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989, 2024, Gut
  • mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model, 2024, Vaccines
  • Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice, 2022, Frontiers in Immunology
  • Can the Remote Use of a Peak Flow Meter Predict Severity of Subglottic Stenosis and Surgical Timing?, 2022, The Laryngoscope
  • OS-032 Long-term hepatitis B surface antigen response after finite treatment with siRNAs ARC-520 or JNJ-3989, 2024, Journal of Hepatology

Frequent collaborators in their research include Kirk Bowling, Lung-Yi Mak, Christine I. Wooddell, Thomas Schluep, and James Hamilton. These co-authors have worked alongside Davis on multiple occasions, contributing to interdisciplinary studies particularly relevant to their fields of expertise.

Best Publications

  • CpG DNA Is a Potent Enhancer of Specific Immunity in Mice Immunized with Recombinant Hepatitis B Surface Antigen

    Heather L. Davis;Risini Weeranta;Thomas J. Waldschmidt;Lorraine Tygrett

  • Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo

    Gunther Hartmann;Risini D. Weeratna;Zuhair K. Ballas;Zuhair K. Ballas;Paul Payette

  • Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

    Jörg Vollmer;Risini Weeratna;Paul Payette;Marion Jurk

  • DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

    Heather L. Davis;Heather L. Davis;Marie-Louise Michel;Robert G. Whalen

  • CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.

    Cynthia L. Brazolot Millan;Risini Weeratna;Arthur M. Krieg;Claire-Anne Siegrist

  • Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

    Arthur M. Krieg;Tong Wu;Risini Weeratna;Susan M. Efler

  • Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle

    Heather L. Davis;Barbara A. Demeneix;Béatrice Quantin;Josée Coulombe

  • The role of CpG dinucleotides in DNA vaccines.

    Arthur M. Krieg;Arthur M. Krieg;Ae-Kyung Yi;Joachim Schorr;Heather L. Davis

  • CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B ® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

    C.L. Cooper;H.L. Davis;M.L. Morris;S.M. Efler

  • CpG DNA induces stronger immune responses with less toxicity than other adjuvants.

    Risini D Weeratna;Michael J McCluskie;Yu Xu;Yu Xu;Heather L Davis

  • DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

    Marie-Louise Michel;Heather L. Davis;Martin Schleef;Maryline Mancini

  • CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.

    Michael J. McCluskie;Heather L. Davis

  • Divergent Therapeutic and Immunologic Effects of Oligodeoxynucleotides with Distinct CpG Motifs

    Zuhair K. Ballas;Arthur M. Krieg;Arthur M. Krieg;Arthur M. Krieg;Thomas Warren;Wendy Rasmussen;Wendy Rasmussen

  • Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist.

    Arthur M. Krieg;Susan M. Efler;Michael Wittpoth;Mohammed J. Al Adhami

  • Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.

    C.L Cooper;H.L Davis;M.L Morris;S.M Efler

  • DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.

    Heather L. Davis;Michael J. McCluskie;John L. Gerin;Robert H. Purcell

  • Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract

    W. Scott Gallichan;Robert N. Woolstencroft;Tina Guarasci;Michael J. McCluskie;Michael J. McCluskie

  • Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.

    Michael J. McCluskie;Michael J. McCluskie;Cynthia L. Brazolot Millan;Robert A. Gramzinski;Harriet L. Robinson

  • Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen.

    Heather L Davis;Marie-Louise Michel;Maryline Mancini;Martin Schleef

  • CpG Oligodeoxynucleotides Can Circumvent the Th2 Polarization of Neonatal Responses to Vaccines But May Fail to Fully Redirect Th2 Responses Established by Neonatal Priming

    Jiri Kovarik;Paola Bozzotti;Laurie Love-Homan;Maria Pihlgren

Frequent Co-Authors

Arthur M. Krieg
Arthur M. Krieg University of Massachusetts Chan Medical School
Marie-Louise Michel
Marie-Louise Michel Institut Pasteur
Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Pierre Tiollais
Pierre Tiollais Institut Pasteur
Claire-Anne Siegrist
Claire-Anne Siegrist University of Geneva
Jonathan B. Angel
Jonathan B. Angel University of Ottawa
Barbara A. Demeneix
Barbara A. Demeneix Centre national de la recherche scientifique, CNRS
Bernard J. Jasmin
Bernard J. Jasmin University of Ottawa
Isa K. Mushahwar
Isa K. Mushahwar Abbott (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career paths in healthcare and research. Many professionals choose to complement their scientific background by pursuing nursing degrees, which provide practical clinical skills and expand job opportunities. For non-nurses interested in entering the nursing field, enrolling in online BSN programs for non nurses offers a flexible and efficient way to get started.

Advanced practice roles are also popular, with numerous nurses advancing through accelerated FNP programs that help them gain family nurse practitioner certification quickly. Those seeking specialization often explore pathways like acute care NP certification, which focuses on managing critically ill patients and enhances career flexibility.

Salary potential is a crucial consideration when planning your career. For instance, understanding the DNP salary by state can inform decisions about where to practice and which certifications to pursue, maximizing your financial return.

Combining immunology knowledge with these nursing qualifications can lead to rewarding opportunities in clinical research, healthcare leadership, and specialized patient care. Exploring these related online degrees and career pathways can be a strategic move for long-term success.

Best Scientists Citing Heather L. Davis

Trending Scientists

Recently Published Articles